New carbonyl compound from cinnamaldehyde
pdf

Keywords

cinnamaldehyde
pyruvic acid
2-oxo-6-phenylhexa-3,5-dienoic acid
biological activity

How to Cite

CIURSIN, A., RUSNAC, R. and GULEA, A. (2023) “New carbonyl compound from cinnamaldehyde”, One Health & Risk Management , p. 86. Available at: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/666 (Accessed: 31August2025).

Abstract

Introduction. Cancer, bacterial, and viral diseases stand as some of the most pressing challenges in modern society. Addressing these issues necessitates the development of new drugs. Promising substances in this context include Schiff bases and their derivatives, such as thiosemicarbazones. The scientific literature indicates that these compounds exhibit various biological properties, including antimicrobial, anticancer, antitumor, antiviral, and antifungal activities. However, the toxicity and efficacy of these compounds are closely tied to their chemical structures. Of particular interest is the functionalization of natural compounds with established biological activities and low toxicity to humans. Cinnamaldehyde, derived from cinnamon tree bark through steam distillation, is one such substance. It finds use in the food and perfume industry owing to its low toxicity and characteristic cinnamon aroma. Notably, the specialty literature points out that Schiff bases derived from cinnamaldehyde are virtually insoluble in water, which presents a significant drawback. This limitation can potentially be addressed through the functionalization of cinnamaldehyde with a substance containing polar groups. In this abstract, pyruvic acid, a ketoacid involved in the Krebs cycle, is considered. It readily undergoes a condensation reaction, specifically a Claisen-Schmidt condensation, with cinnamaldehyde to yield a new ketoacid-containing product. This product is expected to be water-soluble and possess certain biological properties. This opens up the possibility of using the compound as a carbonyl compound in condensation reactions with primary amines (drugs) to form Schiff bases.

The aim. Claisen-Schmidt condensation of cinnamaldehyde with pyruvic acid and confirmation of the product structure with modern physicochemical methods, by nuclear magnetic resonance (NMR) and Fourier transform infrared (FTIR) spectroscopy, for further biological research.

Material and methods. Synthesis of 2-oxo-6-phenylhexa-3,5-dienoic acid. In an Erlenmeyer flask, an equimolar mixture of cinnamaldehyde and pyruvic acid was added in the presence of methanol as a solvent. While continuously stirring, two equivalents of sodium hydroxide in methanol were added dropwise to form a yellow precipitate. The reaction mixture was stirred for an additional 90 minutes. The resulting solid was then filtered, washed with water and cold methanol, and dried at room temperature, yielding a yellow solid with a 72-80% yield. Structural analysis of the newly synthesized compound was carried out using nuclear magnetic resonance (NMR) and Fourier-transform infrared (FTIR) spectroscopy. All initial chemical reagents were sourced from specialized companies.

Results. The 2-oxo-6-phenylhexa-3,5-dienoic acid was synthetized with good yield. NMR spectroscopy was used to confirm its structure and functional groups were analyzed by FTIR.

Conclusions. The 2-oxo-6-phenylhexa-3,5-dienoic acid was synthetized in a form of a yellow precipitate, with a good yield. Its structure was confirmed through NMR and FTIR spectroscopy. The newly synthesized compound in the form of sodium salt exhibits good solubility in water. This observation leads us to anticipate that thiosemicarbazones derived from this carbonyl compound will also be water-soluble.

pdf

|Views: 77| |pdf Downloads: 18|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370